Literature DB >> 18213619

Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.

Steve R Martinez1, Anthony S Robbins, Frederick J Meyers, Richard J Bold, Vijay P Khatri, James E Goodnight.   

Abstract

BACKGROUND: Limb preservation is preferred to amputation for patients with extremity soft tissue sarcoma (ESTS). Disparities in the treatment and outcomes of several malignancies have been reported, but not for ESTS. The authors assessed racial/ethnic differences in patient- and tumor-specific characteristics, treatment, and disease-specific survival in a population of adults with ESTS.
METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was used to identify 6406 adult patients with ESTS who were diagnosed and treated between 1988 and 2003. Patients were categorized into 1 of 4 racial/ethnic groups: whites, blacks, Hispanics, and Asians. Comparisons of treatment and disease-specific survival were conducted with regression models that adjusted for patient age, sex, SEER geographic region, extent of disease, tumor grade, tumor size, and histology.
RESULTS: Relative to whites, blacks received lower rates of adjuvant radiation with surgery (odds ratio [OR], 0.77; 95% confidence interval [95% CI], 0.66-0.90). Hispanics received significantly lower rates of limb-sparing surgery (OR, 0.76; 95% CI, 0.59-0.97). In a multivariate analysis controlling for patient age, sex, SEER geographic region, extent of disease, tumor grade, tumor size, and histology, blacks displayed a worse disease-specific survival (hazard ratio [HR] 1.39; 95% CI, 1.13-1.70), whereas Asians demonstrated superior disease-specific survival (HR, 0.67; 95% CI, 0.46-0.97).
CONCLUSIONS: There were significant racial/ethnic differences in treatment and survival among adults with ESTS. Compared with whites, survival was poorer for blacks but better for Asians. These disparities were not explained by differences in patient or tumor characteristics.

Entities:  

Mesh:

Year:  2008        PMID: 18213619     DOI: 10.1002/cncr.23261

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Disparities in Adolescent and Young Adult Sarcoma Survival: Analyses of the Texas Cancer Registry and the National SEER Data.

Authors:  Jaqueline C Avila; J Andrew Livingston; Ana M Rodriguez; Anne C Kirchhoff; Yong-Fang Kuo; Sapna Kaul
Journal:  J Adolesc Young Adult Oncol       Date:  2018-08-10       Impact factor: 2.223

2.  Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.

Authors:  Warren H Tseng; Thomas R Stevenson; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold; Steve R Martinez
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

3.  Tumor location predicts survival in cutaneous head and neck melanoma.

Authors:  Warren H Tseng; Steve R Martinez
Journal:  J Surg Res       Date:  2010-11-10       Impact factor: 2.192

4.  Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.

Authors:  Steve R Martinez; Shannon H Beal; Steven L Chen; Robert J Canter; Vijay P Khatri; Allen Chen; Richard J Bold
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-07       Impact factor: 7.038

5.  Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

Authors:  Min Yi; Elizabeth A Mittendorf; Janice N Cormier; Thomas A Buchholz; Karl Bilimoria; Aysegul A Sahin; Gabriel N Hortobagyi; Ana Maria Gonzalez-Angulo; Sheng Luo; Aman U Buzdar; Jaime R Crow; Henry M Kuerer; Kelly K Hunt
Journal:  J Clin Oncol       Date:  2011-11-14       Impact factor: 44.544

6.  Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.

Authors:  Min Yi; Sharon Hermes Giordano; Funda Meric-Bernstam; Elizabeth A Mittendorf; Henry M Kuerer; Rosa F Hwang; Isabelle Bedrosian; Loren Rourke; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2010-09-19       Impact factor: 5.344

7.  Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional Analysis.

Authors:  Akshay Tiwari; Swati Shah; Ashwani Kumar Sharma; Sandeep Mehta; Ullas Batra; S K Sharma; A K Dewan
Journal:  Indian J Surg Oncol       Date:  2016-11-02

8.  Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?

Authors:  Aaron M Gazendam; Patricia Schneider; Andre Spiguel; Michelle Ghert
Journal:  Ann Surg Oncol       Date:  2022-07-21       Impact factor: 4.339

9.  Measuring racial/ethnic disparities across the distribution of health care expenditures.

Authors:  Benjamin Lê Cook; Willard G Manning
Journal:  Health Serv Res       Date:  2009-07-27       Impact factor: 3.402

10.  Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era.

Authors:  Shannon H Beal; Steve R Martinez; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold
Journal:  Med Oncol       Date:  2010-01-05       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.